SHANGHAI, CHINA, April 3rd, 2023—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as "BioPerfectus") is proud to announce the launch of two new products, which obtained FDA and CE certification: Automated Nucleic Acid Extraction Workstation SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). These products are designed to automate STD and HPV detection.
SAW-48 is an in-vitro diagnostic medical device that combines sample loading, nucleic acid purification, and PCR setup functions (PCR master mix preparation and nucleic acid pipetting) into one instrument. It has the same basic functions as SAW-96 but is smaller and lighter. The device can process up to 48 samples simultaneously, significantly reducing the turnaround time for test results. SAW-48 automates sample loading, nucleic acid purification, and PCR setup, making STD and HPV detection more efficient.
Cell Nucleic Acid Extraction Kit (Magnetic Bead Method) is a complementary product to the SAW-48. It is designed for the extraction, enrichment, and purification of nucleic acids from various samples, including cervical swabs and liquid-based cells, which are the most common sample types for STD and HPV detection.
The combination of SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method) facilitates automated STD and HPV detection. The automated process reduces the risk of exposure to samples and infection for laboratory personnel. It also enhances efficiency, reduces turnaround time, and increases the accuracy of results.
BioPerfectus remains committed to providing STD and HPV reliable solutions to the in-vitro diagnostic market. As a pioneer in the field of molecular diagnostics, BioPerfectus consistently pursues excellence, embraces innovation, and remains dedicated to addressing the health challenges faced by humanity in pursuit of a healthier future.